Halozyme Therapeutics IncNASDAQ:HALO
- LAST PRICE56.2300
- TODAY'S CHANGE (%)0.2600 (0.4645%)
- Bid / Lots56.2400/ 31
- Ask / Lots57.1000/ 4
- Open / Previous Close56.0800 / 55.9700
- Day Range
- 52 Week Range
- Volume831,949
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | HALO |
|---|---|---|
| 09:32 ET | 13308 | 56.125 |
| 09:34 ET | 1900 | 56.26 |
| 09:36 ET | 3308 | 56.61 |
| 09:38 ET | 2505 | 56.77 |
| 09:39 ET | 2479 | 56.5135 |
| 09:41 ET | 6500 | 56.51 |
| 09:43 ET | 1008 | 56.39 |
| 09:45 ET | 5154 | 56.77 |
| 09:48 ET | 873 | 56.81 |
| 09:50 ET | 1100 | 56.825 |
| 09:52 ET | 900 | 56.8 |
| 09:54 ET | 1500 | 56.9 |
| 09:56 ET | 1050 | 56.855 |
| 09:57 ET | 2104 | 56.9087 |
| 09:59 ET | 8106 | 56.805 |
| 10:01 ET | 5978 | 56.99 |
| 10:03 ET | 1846 | 56.96 |
| 10:06 ET | 1400 | 57.015 |
| 10:08 ET | 2979 | 56.77 |
| 10:10 ET | 474 | 56.7089 |
| 10:12 ET | 2680 | 56.764 |
| 10:14 ET | 3084 | 56.545 |
| 10:15 ET | 1364 | 56.5443 |
| 10:17 ET | 1500 | 56.63 |
| 10:19 ET | 600 | 56.5 |
| 10:21 ET | 1310 | 56.56 |
| 10:24 ET | 1090 | 56.6 |
| 10:26 ET | 440 | 56.6001 |
| 10:28 ET | 185 | 56.63 |
| 10:30 ET | 853 | 56.55 |
| 10:32 ET | 13601 | 56.36 |
| 10:33 ET | 1967 | 56.25 |
| 10:35 ET | 1700 | 56.295 |
| 10:37 ET | 308 | 56.3 |
| 10:39 ET | 1210 | 56.45 |
| 10:42 ET | 1280 | 56.48 |
| 10:44 ET | 1500 | 56.41 |
| 10:46 ET | 1537 | 56.38 |
| 10:48 ET | 1200 | 56.42 |
| 10:50 ET | 1696 | 56.39 |
| 10:51 ET | 577 | 56.33 |
| 10:53 ET | 600 | 56.21 |
| 10:55 ET | 959 | 56.19 |
| 10:57 ET | 700 | 56.18 |
| 11:00 ET | 100 | 56.21 |
| 11:02 ET | 700 | 56.24 |
| 11:04 ET | 600 | 56.29 |
| 11:06 ET | 600 | 56.21 |
| 11:08 ET | 200 | 56.19 |
| 11:09 ET | 1200 | 56.275 |
| 11:11 ET | 6500 | 56.2416 |
| 11:13 ET | 2000 | 56.32 |
| 11:15 ET | 400 | 56.19 |
| 11:18 ET | 700 | 56.25 |
| 11:20 ET | 200 | 56.2257 |
| 11:22 ET | 600 | 56.32 |
| 11:24 ET | 1443 | 56.355 |
| 11:26 ET | 1106 | 56.37 |
| 11:27 ET | 1365 | 56.375 |
| 11:29 ET | 2100 | 56.42 |
| 11:31 ET | 700 | 56.45 |
| 11:33 ET | 1600 | 56.4306 |
| 11:36 ET | 400 | 56.42 |
| 11:38 ET | 650 | 56.44 |
| 11:40 ET | 798 | 56.4699 |
| 11:42 ET | 3762 | 56.4191 |
| 11:44 ET | 1223 | 56.39 |
| 11:45 ET | 1200 | 56.41 |
| 11:47 ET | 1900 | 56.38 |
| 11:49 ET | 463 | 56.38 |
| 11:51 ET | 200 | 56.37 |
| 11:54 ET | 5800 | 56.45 |
| 11:56 ET | 3234 | 56.42 |
| 11:58 ET | 1300 | 56.38 |
| 12:00 ET | 1900 | 56.45 |
| 12:02 ET | 200 | 56.45 |
| 12:03 ET | 600 | 56.48 |
| 12:05 ET | 1600 | 56.47 |
| 12:07 ET | 400 | 56.465 |
| 12:09 ET | 400 | 56.485 |
| 12:12 ET | 1174 | 56.45 |
| 12:14 ET | 1000 | 56.45 |
| 12:16 ET | 2122 | 56.46 |
| 12:18 ET | 700 | 56.455 |
| 12:20 ET | 2830 | 56.46 |
| 12:21 ET | 600 | 56.41 |
| 12:23 ET | 3539 | 56.35 |
| 12:25 ET | 500 | 56.36 |
| 12:27 ET | 300 | 56.335 |
| 12:30 ET | 3798 | 56.34 |
| 12:32 ET | 200 | 56.32 |
| 12:34 ET | 2490 | 56.32 |
| 12:36 ET | 2700 | 56.2273 |
| 12:38 ET | 500 | 56.26 |
| 12:39 ET | 700 | 56.25 |
| 12:41 ET | 3000 | 56.35 |
| 12:43 ET | 1701 | 56.31 |
| 12:45 ET | 600 | 56.3 |
| 12:50 ET | 400 | 56.25 |
| 12:52 ET | 100 | 56.24 |
| 12:54 ET | 2980 | 56.11 |
| 12:56 ET | 900 | 56.11 |
| 12:57 ET | 3151 | 56.11 |
| 12:59 ET | 300 | 56.175 |
| 01:01 ET | 1296 | 56.15 |
| 01:03 ET | 300 | 56.04 |
| 01:06 ET | 1106 | 56.02 |
| 01:08 ET | 1175 | 55.92 |
| 01:10 ET | 571 | 55.92 |
| 01:12 ET | 1100 | 55.94 |
| 01:14 ET | 702 | 55.9 |
| 01:15 ET | 500 | 55.87 |
| 01:17 ET | 1500 | 55.89 |
| 01:19 ET | 664 | 55.8932 |
| 01:21 ET | 800 | 55.92 |
| 01:24 ET | 1372 | 55.88 |
| 01:26 ET | 800 | 55.91 |
| 01:28 ET | 620 | 55.8975 |
| 01:30 ET | 1312 | 55.91 |
| 01:32 ET | 620 | 55.86 |
| 01:33 ET | 500 | 55.85 |
| 01:35 ET | 5376 | 55.64 |
| 01:37 ET | 4338 | 55.7 |
| 01:39 ET | 900 | 55.73 |
| 01:42 ET | 1100 | 55.8 |
| 01:46 ET | 2031 | 55.885 |
| 01:48 ET | 1000 | 55.92 |
| 01:50 ET | 857 | 55.835 |
| 01:51 ET | 3657 | 55.89 |
| 01:53 ET | 200 | 55.915 |
| 01:55 ET | 650 | 55.89 |
| 01:57 ET | 1285 | 55.94 |
| 02:00 ET | 475 | 55.94 |
| 02:02 ET | 200 | 55.935 |
| 02:04 ET | 2597 | 55.95 |
| 02:06 ET | 1255 | 55.86 |
| 02:08 ET | 800 | 55.89 |
| 02:09 ET | 300 | 55.92 |
| 02:11 ET | 400 | 55.965 |
| 02:13 ET | 500 | 55.93 |
| 02:15 ET | 900 | 55.94 |
| 02:20 ET | 1900 | 55.88 |
| 02:22 ET | 1639 | 55.88 |
| 02:24 ET | 1449 | 55.84 |
| 02:26 ET | 2955 | 55.875 |
| 02:27 ET | 1035 | 55.89 |
| 02:29 ET | 1378 | 55.9786 |
| 02:31 ET | 378 | 55.91 |
| 02:33 ET | 1056 | 55.9249 |
| 02:36 ET | 700 | 55.98 |
| 02:38 ET | 2173 | 56 |
| 02:40 ET | 278 | 56.0399 |
| 02:42 ET | 1000 | 55.98 |
| 02:44 ET | 500 | 55.98 |
| 02:45 ET | 700 | 55.9416 |
| 02:47 ET | 1085 | 55.96 |
| 02:49 ET | 400 | 55.94 |
| 02:51 ET | 1423 | 55.95 |
| 02:54 ET | 700 | 55.925 |
| 02:56 ET | 900 | 55.915 |
| 02:58 ET | 1200 | 55.97 |
| 03:00 ET | 900 | 55.95 |
| 03:02 ET | 400 | 55.875 |
| 03:03 ET | 2357 | 55.9 |
| 03:05 ET | 300 | 55.83 |
| 03:07 ET | 2260 | 55.89 |
| 03:09 ET | 1000 | 55.95 |
| 03:12 ET | 1315 | 55.93 |
| 03:14 ET | 1286 | 55.94 |
| 03:16 ET | 1200 | 55.95 |
| 03:18 ET | 600 | 55.94 |
| 03:20 ET | 818 | 55.93 |
| 03:21 ET | 2000 | 55.98 |
| 03:23 ET | 400 | 56 |
| 03:25 ET | 607 | 56.06 |
| 03:27 ET | 1500 | 56.07 |
| 03:30 ET | 800 | 56.055 |
| 03:32 ET | 1700 | 56 |
| 03:34 ET | 400 | 55.93 |
| 03:36 ET | 1413 | 55.93 |
| 03:38 ET | 2175 | 55.98 |
| 03:39 ET | 3072 | 56.01 |
| 03:41 ET | 2097 | 56.05 |
| 03:43 ET | 2265 | 56.02 |
| 03:45 ET | 2571 | 56.04 |
| 03:48 ET | 1969 | 56.05 |
| 03:50 ET | 3932 | 56.03 |
| 03:52 ET | 10240 | 56.065 |
| 03:54 ET | 4200 | 56.015 |
| 03:56 ET | 9976 | 56.15 |
| 03:57 ET | 14403 | 56.18 |
| 03:59 ET | 22556 | 56.23 |
Jul 23, 2024
Halozyme to Report Second Quarter 2024 Financial and Operating Results, from 8:30AM ET on Tuesday Jul 23, 2024 by Dow Jones
8:30AM ET on Tuesday Jul 23, 2024 by Dow Jones
Jul 22, 2024
DJ Halozyme Therapeutics Is Maintained at Neutral by Goldman Sachs, from 9:44AM ET on Monday Jul 22, 2024 by Dow Jones
9:44AM ET on Monday Jul 22, 2024 by Dow Jones
Jul 16, 2024
DJ Halozyme Therapeutics Price Target Maintained With a $65.00/Share by HC Wainwright & Co., from 7:56AM ET on Tuesday Jul 16, 2024 by Dow Jones
7:56AM ET on Tuesday Jul 16, 2024 by Dow Jones
Jun 26, 2024
DJ Halozyme Therapeutics Price Target Maintained With a $65.00/Share by HC Wainwright & Co., from 12:26PM ET on Wednesday Jun 26, 2024 by Dow Jones
12:26PM ET on Wednesday Jun 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Halozyme Therapeutics Inc | 7.1B | 23.3x | --- |
Ionis Pharmaceuticals Inc | 7.6B | -19.3x | --- |
Tempus AI Inc | 6.6B | -23.6x | --- |
Intra-Cellular Therapies Inc | 8.5B | -69.8x | --- |
Blueprint Medicines Corp | 7.1B | -23.3x | --- |
ACADIA Pharmaceuticals Inc | 3.1B | -1,487.2x | --- |
Company Information
Halozyme Therapeutics, Inc. is a biopharmaceutical company advancing disruptive solutions to improve patient experiences and outcomes for emerging and established therapies. The Company’s ENHANZE drug delivery technology with the proprietary enzyme rHuPH20, its commercially validated solution is used to facilitate the subcutaneous (SC) delivery of injected drugs and fluids, with a focus on reducing treatment burden for patients. It also develops, manufactures, and commercializes, for itself or with partners, drug-device combination products using its advanced auto-injector technologies. The Company has two commercial proprietary products, Hylenex and XYOSTED, partnered commercial products and ongoing product development programs with several pharmaceutical companies. It markets and sells Hylenex recombinant, which is a formulation of rHuPH20. It markets and sells its proprietary product XYOSTED for SC administration of testosterone replacement therapy (TRT) in adult males.
Contact Information
- Headquarters
- 12390 EL CAMINO REALSAN DIEGO, CA, United States 92130
- Phone
- 858-794-8889
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- Jeffrey Henderson
- President, Chief Executive Officer, Director
- Helen Torley
- Chief Financial Officer, Senior Vice President
- Nicole Labrosse
- Senior Vice President, Chief Technical Officer
- Michael Labarre
- Senior Vice President, Chief Compliance Officer, General Counsel, Secretary
- Mark Snyder
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $7.1B |
|---|---|
Revenue (TTM) | $863.0M |
Shares Outstanding | 127.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.26 |
EPS | $2.42 |
Book Value | $0.66 |
P/E Ratio | 23.3x |
Price/Sales (TTM) | 8.3 |
Price/Cash Flow (TTM) | 17.8x |
Operating Margin | 43.95% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
